المؤلفون: Lazar, I, Fabre, B, Feng, YM, Khateb, A, Turko, P, Gomez, JMM, Frederick, DT, Levesque, MP, Feld, L, Zhang, G, Zhang, TW, James, B, Shklover, J, Avitan-Hersh, E, Livneh, I, Scortegagna, M, Brown, K, Larsson, O, Topisirovic, I, Wolfenson, H, Herlyn, M, Flaherty, K, Dummer, R, Ronai, ZA

المصدر: Molecular cancer research : MCR. 18(10):1560-1573

مصطلحات موضوعية: Medicin och hälsovetenskap, Klinisk medicin, Cancer och onkologi, Medicinska och farmaceutiska grundvetenskaper, Cell- och molekylärbiologi

URL الوصول: http://kipublications.ki.se/Default.aspx?queryparsed=id:144832780

المؤلفون: Wei S, Du K, Lan H, Yang Z, Deng Y, Wei Z, Frederick DT, Lee J, Labrie M, Tian T, Moll T, Chen Y, Sullivan RJ, Mills G, Boland GM, Flaherty KT, Liu L, Herlyn M, Zhang G

المصدر: BioRxiv : the preprint server for biology [bioRxiv] 2024 Sep 15. Date of Electronic Publication: 2024 Sep 15.

نوع المنشور: Journal Article; Preprint

بيانات الدورية: Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE

المؤلفون: Friedman AA, Amzallag A, Pruteanu-Malinici I, Baniya S, Cooper ZA, Piris A, Hargreaves L, Igras V, Frederick DT, Lawrence DP, Haber DA, Flaherty KT, Wargo JA, Ramaswamy S, Benes CH, Fisher DE

المصدر: PloS one [PLoS One] 2024 Jul 01; Vol. 19 (7), pp. e0306658. Date of Electronic Publication: 2024 Jul 01 (Print Publication: 2024).

نوع المنشور: Published Erratum

بيانات الدورية: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: PubMed not MEDLINE; MEDLINE

المؤلفون: Widman AJ; New York Genome Center, New York, NY, USA. widmana@mskcc.org.; Memorial Sloan Kettering Cancer Center, New York, NY, USA. widmana@mskcc.org., Shah M; New York Genome Center, New York, NY, USA., Frydendahl A; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark., Halmos D; New York Genome Center, New York, NY, USA.; Weill Cornell Medicine, New York, NY, USA., Khamnei CC; New York Genome Center, New York, NY, USA.; Weill Cornell Medicine, New York, NY, USA., Øgaard N; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark., Rajagopalan S; New York Genome Center, New York, NY, USA.; Weill Cornell Medicine, New York, NY, USA., Arora A; New York Genome Center, New York, NY, USA.; Weill Cornell Medicine, New York, NY, USA., Deshpande A; New York Genome Center, New York, NY, USA.; Weill Cornell Medicine, New York, NY, USA., Hooper WF; New York Genome Center, New York, NY, USA., Quentin J; New York Genome Center, New York, NY, USA.; Weill Cornell Medicine, New York, NY, USA., Bass J; New York Genome Center, New York, NY, USA.; Weill Cornell Medicine, New York, NY, USA., Zhang M; New York Genome Center, New York, NY, USA.; Weill Cornell Medicine, New York, NY, USA., Langanay T; New York Genome Center, New York, NY, USA.; Weill Cornell Medicine, New York, NY, USA., Andersen L; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark., Steinsnyder Z; New York Genome Center, New York, NY, USA., Liao W; New York Genome Center, New York, NY, USA., Rasmussen MH; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark., Henriksen TV; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark., Jensen SØ; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark., Nors J; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark., Therkildsen C; Gastro Unit, Copenhagen University Hospital, Amager - Hvidovre Hospital, Hvidovre, Denmark., Sotelo J; New York Genome Center, New York, NY, USA.; Weill Cornell Medicine, New York, NY, USA., Brand R; New York Genome Center, New York, NY, USA.; Weill Cornell Medicine, New York, NY, USA., Schiffman JS; New York Genome Center, New York, NY, USA.; Weill Cornell Medicine, New York, NY, USA., Shah RH; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Cheng AP; New York Genome Center, New York, NY, USA.; Weill Cornell Medicine, New York, NY, USA., Maher C; Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA., Spain L; Cancer Dynamics Laboratory, The Francis Crick Institute, London, UK.; Renal and Skin Unit, The Royal Marsden NHS Foundation Trust, London, UK., Krause K; Mass General Cancer Center, Massachusetts General Hospital, Boston, MA, USA., Frederick DT; Mass General Cancer Center, Massachusetts General Hospital, Boston, MA, USA., den Brok W; Department of Medical Oncology, BC Cancer Agency, Vancouver, British Columbia, Canada., Lohrisch C; Department of Medical Oncology, BC Cancer Agency, Vancouver, British Columbia, Canada., Shenkier T; Department of Medical Oncology, BC Cancer Agency, Vancouver, British Columbia, Canada., Simmons C; Department of Medical Oncology, BC Cancer Agency, Vancouver, British Columbia, Canada., Villa D; Department of Medical Oncology, BC Cancer Agency, Vancouver, British Columbia, Canada., Mungall AJ; Michael Smith Genome Sciences Centre, Vancouver, British Columbia, Canada., Moore R; Michael Smith Genome Sciences Centre, Vancouver, British Columbia, Canada., Zaikova E; Department of Molecular Oncology, BC Cancer Agency, Vancouver, British Columbia, Canada., Cerda V; Department of Molecular Oncology, BC Cancer Agency, Vancouver, British Columbia, Canada., Kong E; Department of Molecular Oncology, BC Cancer Agency, Vancouver, British Columbia, Canada., Lai D; Department of Molecular Oncology, BC Cancer Agency, Vancouver, British Columbia, Canada., Malbari MS; Weill Cornell Medicine, New York, NY, USA., Marton M; New York Genome Center, New York, NY, USA., Manaa D; New York Genome Center, New York, NY, USA., Winterkorn L; New York Genome Center, New York, NY, USA., Gelmon K; Department of Medical Oncology, BC Cancer Agency, Vancouver, British Columbia, Canada., Callahan MK; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Boland G; Mass General Cancer Center, Massachusetts General Hospital, Boston, MA, USA., Potenski C; New York Genome Center, New York, NY, USA.; Weill Cornell Medicine, New York, NY, USA., Wolchok JD; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Saxena A; Weill Cornell Medicine, New York, NY, USA., Turajlic S; Cancer Dynamics Laboratory, The Francis Crick Institute, London, UK.; Renal and Skin Unit, The Royal Marsden NHS Foundation Trust, London, UK., Imielinski M; New York Genome Center, New York, NY, USA.; Perlmutter Cancer Center, NYU Grossman School of Medicine, New York, NY, USA., Berger MF; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Aparicio S; Department of Molecular Oncology, BC Cancer Agency, Vancouver, British Columbia, Canada.; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada., Altorki NK; Weill Cornell Medicine, New York, NY, USA., Postow MA; Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Weill Cornell Medicine, New York, NY, USA., Robine N; New York Genome Center, New York, NY, USA., Andersen CL; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark., Landau DA; New York Genome Center, New York, NY, USA. dlandau@nygenome.org.; Weill Cornell Medicine, New York, NY, USA. dlandau@nygenome.org.

المصدر: Nature medicine [Nat Med] 2024 Jun; Vol. 30 (6), pp. 1655-1666. Date of Electronic Publication: 2024 Jun 14.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE

مواضيع طبية MeSH: Circulating Tumor DNA*/genetics , Circulating Tumor DNA*/blood , DNA Copy Number Variations* , Machine Learning* , Neoplasm, Residual*/genetics , Tumor Burden*, Humans ; Whole Genome Sequencing ; Neoplasms/genetics ; Neoplasms/blood ; Neoplasms/therapy ; Neoplasms/pathology ; Polymorphism, Single Nucleotide ; Biomarkers, Tumor/genetics ; Biomarkers, Tumor/blood ; Colorectal Neoplasms/genetics ; Colorectal Neoplasms/blood ; Colorectal Neoplasms/pathology ; Lung Neoplasms/genetics ; Lung Neoplasms/blood ; Lung Neoplasms/pathology

المؤلفون: Blewett T; Gerstner Center for Cancer Diagnostics, Broad Institute of MIT and Harvard, Cambridge, MA, United States., Rhoades J; Gerstner Center for Cancer Diagnostics, Broad Institute of MIT and Harvard, Cambridge, MA, United States., Liu R; Gerstner Center for Cancer Diagnostics, Broad Institute of MIT and Harvard, Cambridge, MA, United States., Xiong K; Gerstner Center for Cancer Diagnostics, Broad Institute of MIT and Harvard, Cambridge, MA, United States., Sridhar S; Gerstner Center for Cancer Diagnostics, Broad Institute of MIT and Harvard, Cambridge, MA, United States., Crnjac A; Gerstner Center for Cancer Diagnostics, Broad Institute of MIT and Harvard, Cambridge, MA, United States., Cheng J; Gerstner Center for Cancer Diagnostics, Broad Institute of MIT and Harvard, Cambridge, MA, United States., Lawless AR; Massachusetts General Hospital Cancer Center, Department of Medicine, Massachusetts General Hospital, Boston, MA, United States., Frederick DT; Gerstner Center for Cancer Diagnostics, Broad Institute of MIT and Harvard, Cambridge, MA, United States., Flaherty KT; Massachusetts General Hospital Cancer Center, Department of Medicine, Massachusetts General Hospital, Boston, MA, United States., Makrigiorgos GM; Department of Radiation Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, MA, United States., Adalsteinsson VA; Gerstner Center for Cancer Diagnostics, Broad Institute of MIT and Harvard, Cambridge, MA, United States.

المصدر: Clinical chemistry [Clin Chem] 2024 Feb 07; Vol. 70 (2), pp. 434-443.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 9421549 Publication Model: Print Cited Medium: Internet ISSN: 1530-8561 (Electronic) Linking ISSN: 00099147 NLM ISO Abbreviation: Clin Chem Subsets: MEDLINE

مواضيع طبية MeSH: High-Throughput Nucleotide Sequencing*/methods , Cell-Free Nucleic Acids*, Humans ; Neoplasm, Residual/genetics ; Cohort Studies ; Mutation

المؤلفون: Sun Y; Massachusetts General Hospital Cancer Center, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Revach OY; Massachusetts General Hospital Cancer Center, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Anderson S; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Kessler EA; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Wolfe CH; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Jenney A; Laboratory of Systems Pharmacology, Harvard Program in Therapeutic Sciences, Harvard Medical School, Boston, MA, USA., Mills CE; Laboratory of Systems Pharmacology, Harvard Program in Therapeutic Sciences, Harvard Medical School, Boston, MA, USA., Robitschek EJ; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Davis TGR; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Kim S; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Fu A; Massachusetts General Hospital Cancer Center, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Ma X; Massachusetts General Hospital Cancer Center, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Gwee J; Massachusetts General Hospital Cancer Center, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Tiwari P; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Du PP; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Sindurakar P; Massachusetts General Hospital Cancer Center, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Tian J; Massachusetts General Hospital Cancer Center, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Mehta A; Massachusetts General Hospital Cancer Center, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Schneider AM; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA., Yizhak K; Department of Cell Biology and Cancer Science, Rappaport Faculty of Medicine, Institute of Technology, Technion, Haifa, Israel., Sade-Feldman M; Massachusetts General Hospital Cancer Center, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., LaSalle T; Massachusetts General Hospital Cancer Center, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Sharova T; Division of Surgical Oncology, Department of Surgery, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA., Xie H; Massachusetts General Hospital Cancer Center, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Liu S; Laboratory of Systems Pharmacology, Harvard Program in Therapeutic Sciences, Harvard Medical School, Boston, MA, USA., Michaud WA; Division of Surgical Oncology, Department of Surgery, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA., Saad-Beretta R; Massachusetts General Hospital Cancer Center, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Yates KB; Massachusetts General Hospital Cancer Center, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Iracheta-Vellve A; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Spetz JKE; Laboratory of Systems Pharmacology, Harvard Program in Therapeutic Sciences, Harvard Medical School, Boston, MA, USA.; Molecular and Integrative Physiological Sciences Program, Harvard School of Public Health, Boston, MA, USA.; John B. Little Center for Radiation Sciences, Harvard School of Public Health, Boston, MA, USA., Qin X; Laboratory of Systems Pharmacology, Harvard Program in Therapeutic Sciences, Harvard Medical School, Boston, MA, USA.; Molecular and Integrative Physiological Sciences Program, Harvard School of Public Health, Boston, MA, USA.; John B. Little Center for Radiation Sciences, Harvard School of Public Health, Boston, MA, USA., Sarosiek KA; Laboratory of Systems Pharmacology, Harvard Program in Therapeutic Sciences, Harvard Medical School, Boston, MA, USA.; Molecular and Integrative Physiological Sciences Program, Harvard School of Public Health, Boston, MA, USA.; John B. Little Center for Radiation Sciences, Harvard School of Public Health, Boston, MA, USA., Zhang G; Molecular and Cellular Oncogenesis Program, The Wistar Institute, Philadelphia, PA, USA.; Preston Robert Tisch Brain Tumor Center, Department of Neurosurgery, Duke University School of Medicine, Durham, NC, USA.; Preston Robert Tisch Brain Tumor Center, Department of Pathology, Duke University School of Medicine, Durham, NC, USA., Kim JW; Moores Cancer Center, UC San Diego, La Jolla, CA, USA.; Center for Novel Therapeutics, UC San Diego, La Jolla, CA, USA.; Department of Medicine, UC San Diego, La Jolla, CA, USA., Su MY; Cutaneous Biology Research Center, Department of Dermatology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA., Cicerchia AM; Massachusetts General Hospital Cancer Center, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Rasmussen MQ; Massachusetts General Hospital Cancer Center, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Klempner SJ; Massachusetts General Hospital Cancer Center, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Juric D; Massachusetts General Hospital Cancer Center, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Pai SI; Division of Surgical Oncology, Department of Surgery, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.; Center for Systems Biology, Massachusetts General Hospital, Boston, MA, USA., Miller DM; Massachusetts General Hospital Cancer Center, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.; Department of Dermatology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA., Giobbie-Hurder A; Division of Biostatistics, Department of Data Sciences, Dana-Farber Cancer Institute, Boston, MA, USA., Chen JH; Massachusetts General Hospital Cancer Center, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Department of Pathology, Massachusetts General Hospital, Boston, MA, USA., Pelka K; Massachusetts General Hospital Cancer Center, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Frederick DT; Massachusetts General Hospital Cancer Center, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Stinson S; Gilead Sciences, Foster City, CA, USA., Ivanova E; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, MA, USA., Aref AR; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, MA, USA.; Xsphera Biosciences, Boston, MA, USA., Paweletz CP; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, MA, USA., Barbie DA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, MA, USA., Sen DR; Massachusetts General Hospital Cancer Center, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Fisher DE; Cutaneous Biology Research Center, Department of Dermatology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA., Corcoran RB; Massachusetts General Hospital Cancer Center, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Hacohen N; Massachusetts General Hospital Cancer Center, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Sorger PK; Laboratory of Systems Pharmacology, Harvard Program in Therapeutic Sciences, Harvard Medical School, Boston, MA, USA., Flaherty KT; Massachusetts General Hospital Cancer Center, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Boland GM; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Division of Surgical Oncology, Department of Surgery, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA., Manguso RT; Massachusetts General Hospital Cancer Center, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Jenkins RW; Massachusetts General Hospital Cancer Center, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. rjenkins@mgh.harvard.edu.; Broad Institute of MIT and Harvard, Cambridge, MA, USA. rjenkins@mgh.harvard.edu.; Laboratory of Systems Pharmacology, Harvard Program in Therapeutic Sciences, Harvard Medical School, Boston, MA, USA. rjenkins@mgh.harvard.edu.

المصدر: Nature [Nature] 2023 Mar; Vol. 615 (7950), pp. 158-167. Date of Electronic Publication: 2023 Jan 12.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 0410462 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-4687 (Electronic) Linking ISSN: 00280836 NLM ISO Abbreviation: Nature Subsets: MEDLINE

مواضيع طبية MeSH: Immune Evasion*/genetics , Immune Evasion*/immunology , Immunotherapy*/methods , Protein Serine-Threonine Kinases*/antagonists & inhibitors , Protein Serine-Threonine Kinases*/genetics , Drug Resistance, Neoplasm*, Humans ; Programmed Cell Death 1 Receptor/antagonists & inhibitors ; Organoids ; Tumor Necrosis Factors/immunology ; Interferon-gamma/immunology ; Spheroids, Cellular ; Caspases ; Janus Kinases ; STAT Transcription Factors

المؤلفون: Boshuizen J; Division of Molecular Oncology and Immunology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Vredevoogd DW; Division of Molecular Oncology and Immunology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Krijgsman O; Division of Molecular Oncology and Immunology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Ligtenberg MA; Division of Molecular Oncology and Immunology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Blankenstein S; Division of Surgical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., de Bruijn B; Division of Molecular Oncology and Immunology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Frederick DT; Department of Surgical Oncology, Massachusetts General Hospital, Boston, MA, USA., Kenski JCN; Division of Molecular Oncology and Immunology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Parren M; Division of Molecular Oncology and Immunology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Brüggemann M; Division of Molecular Oncology and Immunology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Madu MF; Division of Surgical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Rozeman EA; Division of Molecular Oncology and Immunology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Song JY; Division of Animal Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Horlings HM; Division of Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Blank CU; Division of Molecular Oncology and Immunology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands., van Akkooi ACJ; Division of Surgical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Flaherty KT; Department of Medical Oncology, Massachusetts General Hospital, Boston, MA, USA., Boland GM; Department of Surgical Oncology, Massachusetts General Hospital, Boston, MA, USA., Peeper DS; Division of Molecular Oncology and Immunology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands. d.peeper@nki.nl.

المصدر: Nature communications [Nat Commun] 2023 Feb 07; Vol. 14 (1), pp. 672. Date of Electronic Publication: 2023 Feb 07.

نوع المنشور: Published Erratum

بيانات الدورية: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: PubMed not MEDLINE; MEDLINE

المؤلفون: Lester DK; Department of Tumor Biology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.; Cancer Biology Ph.D. Program, University of South Florida, Tampa, FL, USA.; Molecular Medicine Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Burton C; Department of Tumor Biology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.; Cancer Biology Ph.D. Program, University of South Florida, Tampa, FL, USA.; Molecular Medicine Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.; Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.; Immunology Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Gardner A; Cancer Biology Ph.D. Program, University of South Florida, Tampa, FL, USA.; Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.; Immunology Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Innamarato P; Cancer Biology Ph.D. Program, University of South Florida, Tampa, FL, USA.; Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.; Immunology Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Kodumudi K; Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.; Immunology Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Liu Q; Department of Tumor Biology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.; Cancer Biology Ph.D. Program, University of South Florida, Tampa, FL, USA.; Molecular Medicine Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Adhikari E; Department of Tumor Biology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.; Cancer Biology Ph.D. Program, University of South Florida, Tampa, FL, USA.; Molecular Medicine Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Ming Q; Molecular Medicine Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.; Department of Drug Discovery, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Williamson DB; Complex Carbohydrate Research Center, the University of Georgia, Athens, GA, USA., Frederick DT; Department of Surgery, Massachusetts General Hospital, Boston, MA, USA., Sharova T; Department of Surgery, Massachusetts General Hospital, Boston, MA, USA., White MG; Department of Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA., Markowitz J; Immunology Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.; Department of Cutaneous Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Cao B; Department of Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Nguyen J; Advanced Analytical and Digital Laboratory, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Johnson J; Department of Analytic Microscopy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Beatty M; Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.; Immunology Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Mockabee-Macias A; Department of Tumor Biology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.; Molecular Medicine Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Mercurio M; Department of Tumor Biology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.; Molecular Medicine Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Watson G; Department of Tumor Biology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.; Molecular Medicine Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Chen PL; Department of Pathology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., McCarthy S; Advanced Analytical and Digital Laboratory, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., MoranSegura C; Advanced Analytical and Digital Laboratory, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Messina J; Department of Pathology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Thomas KL; Department of Diagnostic Imaging, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Darville L; Proteomics and Metabolomics Core, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Izumi V; Proteomics and Metabolomics Core, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Koomen JM; Proteomics and Metabolomics Core, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.; Department of Molecular Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Pilon-Thomas SA; Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.; Immunology Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Ruffell B; Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.; Immunology Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Luca VC; Molecular Medicine Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.; Department of Drug Discovery, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Haltiwanger RS; Complex Carbohydrate Research Center, the University of Georgia, Athens, GA, USA., Wang X; Department of Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Wargo JA; Department of Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA.; Department of Genomic Medicine, MD Anderson Cancer Center, Houston, TX, USA., Boland GM; Department of Surgery, Massachusetts General Hospital, Boston, MA, USA.; Broad Institute of Harvard and Massachusetts Institute of Technology, Massachusetts General Hospital, Boston, MA, USA., Lau EK; Department of Tumor Biology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA. eric.lau@moffitt.org.; Molecular Medicine Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA. eric.lau@moffitt.org.

المصدر: Nature cancer [Nat Cancer] 2023 Feb; Vol. 4 (2), pp. 222-239. Date of Electronic Publication: 2023 Jan 23.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101761119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2662-1347 (Electronic) Linking ISSN: 26621347 NLM ISO Abbreviation: Nat Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Fucose*/metabolism , Melanoma*/drug therapy, Humans ; HLA-DRB1 Chains/genetics ; HLA-DRB1 Chains/metabolism ; Immunotherapy ; CD4-Positive T-Lymphocytes/metabolism ; CD4-Positive T-Lymphocytes/pathology

المؤلفون: Zhao H; Cutaneous Biology Research Center, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA, USA., Teng D; Cutaneous Biology Research Center, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA, USA., Yang L; Department of Chemistry, Princeton University, Princeton, NJ, USA.; Lewis-Sigler Institute for Integrative Genomics, Princeton University, Princeton, NJ, USA.; Shanghai Institute of Nutrition and Health, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, China., Xu X; Department of Chemistry, Princeton University, Princeton, NJ, USA.; Lewis-Sigler Institute for Integrative Genomics, Princeton University, Princeton, NJ, USA., Chen J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Jiang T; Epigenetics Laboratory, Max Planck Institute for Heart and Lung Research, Bad Nauheim, Germany., Feng AY; Cutaneous Biology Research Center, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA, USA., Zhang Y; Department of Surgery, University of Michigan, Ann Arbor, MI, USA., Frederick DT; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, MA, USA., Gu L; Epigenetics Laboratory, Max Planck Institute for Heart and Lung Research, Bad Nauheim, Germany., Cai L; Department of Cancer Biology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Asara JM; Division of Signal Transduction, Beth Israel Deaconess Medical Center and Department of Medicine, Harvard Medical School, Boston, MA, USA., Pasca di Magliano M; Department of Surgery, University of Michigan, Ann Arbor, MI, USA.; Department of Cell and Developmental Biology, University of Michigan, Ann Arbor, MI, USA.; Cancer Biology Program, University of Michigan, Ann Arbor, MI, USA.; Cellular and Molecular Biology Program, University of Michigan, Ann Arbor, MI, USA.; Rogel Cancer Center, University of Michigan, Ann Arbor, MI, USA., Boland GM; Department of Surgery, Massachusetts General Hospital, Boston, MA, USA., Flaherty KT; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, MA, USA., Swanson KD; Cutaneous Biology Research Center, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA, USA., Liu D; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Rabinowitz JD; Department of Chemistry, Princeton University, Princeton, NJ, USA.; Lewis-Sigler Institute for Integrative Genomics, Princeton University, Princeton, NJ, USA.; Ludwig Institute for Cancer Research, Princeton Branch, Princeton, NJ, USA., Zheng B; Cutaneous Biology Research Center, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA, USA. bin.zheng@cbrc2.mgh.harvard.edu.

المصدر: Nature metabolism [Nat Metab] 2022 Dec; Vol. 4 (12), pp. 1660-1673. Date of Electronic Publication: 2022 Nov 14.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Springer Nature Country of Publication: Germany NLM ID: 101736592 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2522-5812 (Electronic) Linking ISSN: 25225812 NLM ISO Abbreviation: Nat Metab Subsets: MEDLINE

مواضيع طبية MeSH: Neoplasms*/metabolism , Myeloid-Derived Suppressor Cells*/metabolism, Mice ; Female ; Animals ; CD8-Positive T-Lymphocytes ; Succinates/pharmacology ; Succinates/metabolism ; Tumor Microenvironment

المؤلفون: Dubrot J; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA.; Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.; Center for Applied Medical Research (CIMA), University of Navarra, Pamplona, Spain., Du PP; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Stanford University School of Medicine, Stanford, CA, USA., Lane-Reticker SK; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Kessler EA; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Muscato AJ; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Mehta A; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA.; Department of Medicine, Massachusetts General Hospital, Boston, MA, USA., Freeman SS; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA.; Department of Medicine, Massachusetts General Hospital, Boston, MA, USA., Allen PM; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Olander KE; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Ockerman KM; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Wolfe CH; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Wiesmann F; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Knudsen NH; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA.; Department of Medicine, Massachusetts General Hospital, Boston, MA, USA., Tsao HW; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Iracheta-Vellve A; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Schneider EM; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Rivera-Rosario AN; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Kohnle IC; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Pope HW; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Ayer A; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Mishra G; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Zimmer MD; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Kim SY; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Mahapatra A; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Ebrahimi-Nik H; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Frederick DT; Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA.; Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.; Department of Surgery, Massachusetts General Hospital, Boston, MA, USA., Boland GM; Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA.; Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.; Department of Surgery, Massachusetts General Hospital, Boston, MA, USA., Haining WN; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.; ArsenalBio, South San Francisco, CA, USA., Root DE; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Doench JG; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Hacohen N; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA.; Department of Medicine, Massachusetts General Hospital, Boston, MA, USA., Yates KB; Broad Institute of MIT and Harvard, Cambridge, MA, USA. yates@broadinstitute.org.; Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA. yates@broadinstitute.org.; Department of Medicine, Massachusetts General Hospital, Boston, MA, USA. yates@broadinstitute.org., Manguso RT; Broad Institute of MIT and Harvard, Cambridge, MA, USA. rmanguso@mgh.harvard.edu.; Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA. rmanguso@mgh.harvard.edu.; Department of Medicine, Massachusetts General Hospital, Boston, MA, USA. rmanguso@mgh.harvard.edu.

المصدر: Nature immunology [Nat Immunol] 2022 Oct; Vol. 23 (10), pp. 1495-1506. Date of Electronic Publication: 2022 Sep 23.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Nature America Inc Country of Publication: United States NLM ID: 100941354 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1529-2916 (Electronic) Linking ISSN: 15292908 NLM ISO Abbreviation: Nat Immunol Subsets: MEDLINE

مواضيع طبية MeSH: CD8-Positive T-Lymphocytes* , Neoplasms*, Clustered Regularly Interspaced Short Palindromic Repeats/genetics ; Histocompatibility Antigens Class I/metabolism ; Humans ; Immune Checkpoint Inhibitors ; Immune Evasion ; Interferon-gamma/genetics ; Interferon-gamma/metabolism ; NK Cell Lectin-Like Receptor Subfamily C